Navigation Links
PharmMD's Brad Tice Named APhA Fellow
Date:3/17/2008

NASHVILLE, Tenn., March 17/PRNewswire/ -- Brad Tice, Pharm.D., chief clinical officer of PharmMD, will be named a fellow of the American Pharmacists Association (APhA) at its upcoming annual meeting, scheduled for March 14-17 in San Diego, Calif.

Among his many career accomplishments, Dr. Tice helped make medication therapy management (MTM) what it is today. MTM refers to the process of preventing drug error, overuse and abuse by ensuring that individual patients receive the most appropriate medications possible. Dr. Tice was a member of the team that wrote the accepted clinical definition of MTM approved by 11 organizations including the APhA. He also participated on the advisory panel that developed the MTM model jointly issued by APhA and NACDS. As evidence of the increasing value and importance of MTM, the Centers for Medicare and Medicaid Services (CMS) began in 2006 requiring each sponsor of its Part D drug benefits to incorporate an MTM program into their plan's benefit structure. CMS leadership has referred to MTM as the "cornerstone" of the Part D Medicare benefit.

Dr. Tice currently serves as chief clinical officer for PharmMD, an MTM provider that works with employers, government plans and other payers to help ensure that beneficiaries are receiving the most appropriate medications by improving coordination and communication among physicians, pharmacists, payers and patients. The company analyzes medical and pharmaceutical utilization records to prevent harmful drug interactions and costly duplications. After only one quarter of providing MTM services to approximately 3,000 covered lives at a large, self-insured employer, PharmMD reported $3 saved for ever $1 spent on its services.

"As our company's clinical leader, Dr. Tice's services have likely saved several lives and improved many more," said Bo Bartholomew, founder and CEO of PharmMD. "He is a pioneer in his industry and a critical member of our executive team."

The APhA Fellow Award was established in 1987 to honor members who have demonstrated progressive, exemplary service and achievements in their professional area through service to APhA academies and other national, state, and local professional organizations. Recipients must have at least 10 years professional pharmacy experience.

Dr. Tice is among only 17 individuals to receive the APhA Fellow Award this year, which is given to a maximum of 20 individuals each year. As a member of the APhA Academy of Pharmacy Practice and Management, Dr. Tice has held numerous leadership positions including member-at-large of the executive committee and chair of the clinical/pharmacotherapeutic section. He sat on the advisory board of the Journal of the American Pharmacists Association for several years and also served as speaker of the house, vice-speaker and member of the board of trustees of the Iowa Pharmacists Association. He has also been actively involved in the Pharmacy Quality Alliance (PQA) and currently serves as the co-chair of its Quality Metrics Workgroup.

"Medication error, overuse and abuse are pressing issues in today's healthcare environment, and, if applied properly, the principles of MTM can go a long way to preventing these negative events," said Dr. Tice. "It is exciting to operate on the cutting edge of such an important healthcare trend."

Dr. Tice began his pharmacy career focusing on the delivery of patient care services for Osco Drug, first as a pharmacist in Kansas City, Kan., and later as a pharmacy manager for Osco Drug in Davenport, Iowa. He later became an assistant and associate professor at the Drake University College of Pharmacy and Health Sciences and Director of the Osco Drug/Drake University Community Care Laboratory. Dr. Tice earned his bachelor's of science and doctorate in pharmacy from the University of Kansas.

Dr. Tice was awarded the Iowa Pharmacy Association Young Pharmacist of the Year in 2001 and the 2005 Alfred B. Prescott/GlaxoSmithKline Leadership Award.

About PharmMD

PharmMD is an MTM provider based in Brentwood, Tenn., that works with employers and payers to help ensure that beneficiaries are receiving the most appropriate medications. Founded in 2006, PharmMD improves coordination and communication among physicians, pharmacists, payers and patients by analyzing pharmacy and medical claims information and clinical decision making. Because PharmMD focuses exclusively on MTM, the company is able to analyze both aggregate and patient-specific data to identify trends and conflicts to positively impact patient health and contain costs. More information at: http://www.pharmmd.com .

About the American Pharmacists Association (APhA)

The American Pharmacists Association is dedicated to improving medication use and advancing patient care. APhA's awards and recognition program is American Pharmacy's most comprehensive recognition program. Founded in 1852 as the American Pharmaceutical Association, APhA is the first-established and largest professional association of pharmacists in the United States. Its more than 60,000 members include pharmacists, scientists, student pharmacists, pharmacy technicians and others interested in advancing the profession.


'/>"/>
SOURCE PharmMD
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Idaho Youth Named National Epilepsy Spokesperson
2. Florida Youth Named National Epilepsy Spokesperson
3. Delaware Youth Named National Epilepsy Spokesperson
4. Colorado Youth Named National Epilepsy Spokesperson
5. Arizona Youth Named National Epilepsy Spokesperson
6. Washington Youth Named National Epilepsy Spokesperson
7. Vermont Youth Named National Epilepsy Spokesperson
8. Wisconsin Youths Named National Epilepsy Spokespersons
9. Virginia Youth Named National Epilepsy Spokesperson
10. Utah Youth Named National Epilepsy Spokesperson
11. Texas Youths Named National Epilepsy Spokespersons
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... Ongoing news ... Aging Life Care Association™ (ALCA) to conduct a survey that takes a closer look ... released today illustrates the prevalence and causes of TBI among the aging population, and ...
(Date:2/10/2016)... ... February 10, 2016 , ... AxoGen, Inc. (NASDAQ: AXGN), a ... for the fourth quarter and full year ended December 31, 2015 on Monday, February ... and webcast for the investment community following the release at 4:30 PM ET. Investors ...
(Date:2/10/2016)... ... ... For additional information contact Phyllis Strupp 480-488-5858 , Brain improves with age, ... Guide to Brain Training" by award-winning author Phyllis Strupp explains how brain ... 16, 2016. A free review copy is available to the media at NetGalley ...
(Date:2/10/2016)... ... 2016 , ... IDEX Health & Science, LLC announces the ... columns combine the strength of traditional stainless steel with the chemical inertness of ... operating at ultra-high pressures of 20,000 psi. The higher operating pressures allow faster ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... The recreational ... cannabis enthusiasts in the state still face a lot of restrictions as to where ... is intended for private, personal use” and that cannabis “may not be consumed openly ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Health, Inc. (Nasdaq: GHDX ) today reported financial results ... 2015. --> --> Revenue was ... million in the fourth quarter of 2014, an increase of 8 ... with the same period in the prior year. ... the fourth quarter of 2015, an increase of 9 percent compared ...
(Date:2/10/2016)... LEXINGTON, Massachusetts , February 10, 2016 --> ... Japan .  --> Japan .  ... Japan .  With submission, Shire continues to ... --> With submission, Shire continues to ... With submission, Shire continues to strengthen ...
(Date:2/10/2016)... and SAN DIEGO , Feb. ... a global leader in viral gene therapy manufacturing, and ... for congestive heart failure and other chronic diseases, have ... scalable manufacturing process and produce cGMP-grade RT-100 (Ad5.hAC6) Drug ... --> --> This ...
Breaking Medicine Technology: